Biallelic PDE2A variants: a new cause of syndromic paroxysmal dyskinesia.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
10 2020
Historique:
received: 31 05 2019
accepted: 28 04 2020
revised: 01 04 2020
pubmed: 30 5 2020
medline: 9 6 2021
entrez: 30 5 2020
Statut: ppublish

Résumé

Cause of complex dyskinesia remains elusive in some patients. A homozygous missense variant leading to drastic decrease of PDE2A enzymatic activity was reported in one patient with childhood-onset choreodystonia preceded by paroxysmal dyskinesia and associated with cognitive impairment and interictal EEG abnormalities. Here, we report three new cases with biallelic PDE2A variants identified by trio whole-exome sequencing. Mitochondria network was analyzed after Mitotracker™ Red staining in control and mutated primary fibroblasts. Analysis of retrospective video of patients' movement disorder and refinement of phenotype was carried out. We identified a homozygous gain of stop codon variant c.1180C>T; p.(Gln394*) in PDE2A in siblings and compound heterozygous variants in young adult: a missense c.446C>T; p.(Pro149Leu) and splice-site variant c.1922+5G>A predicted and shown to produce an out of frame transcript lacking exon 22. All three patients had cognitive impairment or developmental delay. The phenotype of the two oldest patients, aged 9 and 26, was characterized by childhood-onset refractory paroxysmal dyskinesia initially misdiagnosed as epilepsy due to interictal EEG abnormalities. The youngest patient showed a proven epilepsy at the age of 4 months and no paroxysmal dyskinesia at 15 months. Interestingly, analysis of the fibroblasts with the biallelic variants in PDE2A variants revealed mitochondria network morphology changes. Together with previously reported case, our three patients confirm that biallelic PDE2A variants are a cause of childhood-onset refractory paroxysmal dyskinesia with cognitive impairment, sometimes associated with choreodystonia and interictal baseline EEG abnormalities or epilepsy.

Identifiants

pubmed: 32467598
doi: 10.1038/s41431-020-0641-9
pii: 10.1038/s41431-020-0641-9
pmc: PMC7608189
doi:

Substances chimiques

Codon, Nonsense 0
Cyclic Nucleotide Phosphodiesterases, Type 2 EC 3.1.4.17
PDE2A protein, human EC 3.1.4.17

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1403-1413

Références

Bhatia KP. Paroxysmal dyskinesias. Mov Disord. 2011;26:1157–65.
doi: 10.1002/mds.23765
Gardiner AR, Jaffer F, Dale RC, Labrum R, Erro R, Meyer E, et al. The clinical and genetic heterogeneity of paroxysmal dyskinesias. Brain. 2015;138:3567–80.
doi: 10.1093/brain/awv310
McGuire S, Chanchani S, Khurana DS. Paroxysmal dyskinesias. Semin Pediatr Neurol. 2018;25:75–81.
doi: 10.1016/j.spen.2017.12.007
Ebrahimi-Fakhari D, Saffari A, Westenberger A, Klein C. The evolving spectrum of PRRT2-associated paroxysmal diseases. Brain. 2015;138:3476–95.
doi: 10.1093/brain/awv317
Schneider SA, Paisan-Ruiz C, Garcia-Gorostiaga I, Quinn NP, Weber YC, Lerche H, et al. GLUT1 gene mutations cause sporadic paroxysmal exercise-induced dyskinesias. Mov Disord. 2009;24:1684–8.
doi: 10.1002/mds.22507
Erro R, Bhatia KP, Espay AJ, Striano P. The epileptic and nonepileptic spectrum of paroxysmal dyskinesias: channelopathies, synaptopathies, and transportopathies: the pathophysiology of paroxysmal dyskinesias. Mov Disord. 2017;32:310–8.
doi: 10.1002/mds.26901
Chen D-H, Méneret A, Friedman JR, Korvatscha O, Gad A, Bonkowski ES, et al. ADCY5-related dyskinesia: broader spectrum and genotype–phenotype correlations. Neurology. 2015;85:2026–35.
doi: 10.1212/WNL.0000000000002058
Salpietro V, Perez-Dueñas B, Nakashima K, San Antonio-Arce V, Manole A, Efthymiou S, et al. A homozygous loss-of-function mutation in PDE2A associated to early-onset hereditary chorea: a homozygous PDE2A mutation causing chorea. Mov Disord. 2018;33:482–8.
doi: 10.1002/mds.27286
Monterisi S, Lobo MJ, Livie C, Castle C, Weinberger M, Baillie G et al. PDE2A2 regulates mitochondria morphology and apoptotic cell death via local modulation of cAMP/PKA signalling. eLife. 2017;6:1–20.
doi: 10.7554/eLife.21374
Roth S, Heintzmann R. Optical photon reassignment with increased axial resolution by structured illumination. Methods Appl Fluoresc. 2016;4:045005.
doi: 10.1088/2050-6120/4/4/045005
Kirk EP, Barlow-Stewart K, Selvanathan A, Josephi-Taylor S, Worgan L, Rajagopalan S, et al. Beyond the panel: preconception screening in consanguineous couples using the TruSight One “clinical exome”. Genet Med. 2018. https://doi.org/10.1038/s41436-018-0082-9.
doi: 10.1038/s41436-018-0082-9. pubmed: 30327541
Souirti Z, Landré E, Mellerio C, Devaux B, Chassoux F. Neural network underlying ictal pouting (“chapeau de gendarme”) in frontal lobe epilepsy. Epilepsy Behav. 2014;37:249–57.
doi: 10.1016/j.yebeh.2014.07.009
Exome Aggregation Consortium, Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–91.
doi: 10.1038/nature19057
Coubes P, Roubertie A, Vayssiere N, Hemm S, Echenne B. Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus. Lancet. 2000;355:2220–1.
doi: 10.1016/S0140-6736(00)02410-7
van Coller R, Slabbert P, Vaidyanathan J, Schutte C. Successful treatment of disabling paroxysmal nonkinesigenic dyskinesia with deep brain stimulation of the globus pallidus internus. Stereotact Funct Neurosurg. 2014;92:388–92.
doi: 10.1159/000365226
Candela S, Vanegas MI, Darling A, Ortigoza-Escobar JD, Alamar M, Muchart J, et al. Frameless robot-assisted pallidal deep brain stimulation surgery in pediatric patients with movement disorders: precision and short-term clinical results. J Neurosurg Pediatr. 2018;22:416–25.
doi: 10.3171/2018.5.PEDS1814
Narayanan DL, Deshpande D, Das Bhowmik A, Varma DR, Dalal A. Familial choreoathetosis due to novel heterozygous mutation in PDE10A. Am J Med Genet A. 2018;176:146–50.
doi: 10.1002/ajmg.a.38507
Carecchio M, Mencacci NE. Emerging monogenic complex hyperkinetic disorders. Curr Neurol Neurosci Rep. 2017;17:97–107. https://doi.org/10.1007/s11910-017-0806-2 .
doi: 10.1007/s11910-017-0806-2 pubmed: 29086067 pmcid: 5662693
Niccolini F, Mencacci NE, Yousaf T, Rabiner EA, Salpietro V, Pagano G et al. PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology: PDE10A and ADCY5 Mutations Pathology. Mov Disord. 2018;33:1961–65. https://doi.org/10.1002/mds.27523 .
doi: 10.1002/mds.27523 pubmed: 30345538
Conti M, Beavo J. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem. 2007;76:481–511.
doi: 10.1146/annurev.biochem.76.060305.150444
Bender AT, Beavo JA. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev. 2006;58:488–520.
doi: 10.1124/pr.58.3.5
Bingham J, Sudarsanam S, Srinivasan S. Profiling human phosphodiesterase genes and splice isoforms. Biochem Biophys Res Commun. 2006;350:25–32.
doi: 10.1016/j.bbrc.2006.08.180
Bender AT, Beavo JA. Specific localized expression of cGMP PDEs in Purkinje neurons and macrophages. Neurochem Int. 2004;45:853–7.
doi: 10.1016/j.neuint.2004.03.015
Shelly M, Lim BK, Cancedda L, Heilshorn SC, Gao H, Poor MM. Local and long-range reciprocal regulation of cAMP and cGMP in axon/dendrite formation. Science. 2010;327:547–52.
doi: 10.1126/science.1179735
Shen K, Cowan CW. Guidance molecules in synapse formation and plasticity. Cold Spring Harb Perspect Biol. 2010;2:a001842.
doi: 10.1101/cshperspect.a001842
Averaimo S, Nicol X. Intermingled cAMP, cGMP and calcium spatiotemporal dynamics in developing neuronal circuits. Front Cell Neurosci. 2014;8:1–10. https://doi.org/10.3389/fncel.2014.00376 .
doi: 10.3389/fncel.2014.00376
Akiyama H, Fukuda T, Tojima T, Nikolaev VO, Kamiguchi H. Cyclic nucleotide control of microtubule dynamics for axon guidance. J Neurosci. 2016;36:5636–49.
doi: 10.1523/JNEUROSCI.3596-15.2016
Diggle CP, Sukoff Rizzo SJ, Popiolek M, Hinttala R, Schülke JP, Kurian MA, et al. Biallelic mutations in PDE10A lead to loss of striatal PDE10A and a hyperkinetic movement disorder with onset in infancy. Am J Hum Genet. 2016;98:735–43.
doi: 10.1016/j.ajhg.2016.03.015
Mencacci NE, Kamsteeg E-J, Nakashima K, R’Bibo L, Lynch DS, Balint B, et al. De Novo mutations in PDE10A cause childhood-onset chorea with bilateral striatal lesions. Am J Hum Genet. 2016;98:763–71.
doi: 10.1016/j.ajhg.2016.02.015
Chang FCF, Westenberger A, Dale RC, Smith M, Pall HS, Perez-Duenas B, et al. Phenotypic insights into ADCY5-associated disease. Mov Disord J Mov Disord Soc. 2016;31:1033–40.
doi: 10.1002/mds.26598
Friedman JR, Méneret A, Chen D-H, Trouillard O, Vidailhet M, Raskind WH, et al. ADCY5 mutation carriers display pleiotropic paroxysmal day and nighttime dyskinesias. Mov Disord J Mov Disord Soc. 2016;31:147–8.
doi: 10.1002/mds.26494
Acin-Perez R, Russwurm M, Günnewig K, Gertz M, Zoidl G, Ramos L, et al. A phosphodiesterase 2A isoform localized to mitochondria regulates respiration. J Biol Chem. 2011;286:30423–32.
doi: 10.1074/jbc.M111.266379
Smirnova E, Shurland DL, Ryazantsev SN, van der Bliek AM. A human dynamin-related protein controls the distribution of mitochondria. J Cell Biol. 1998;143:351–8.
doi: 10.1083/jcb.143.2.351
Huang P, Yu T, Yoon Y. Mitochondrial clustering induced by overexpression of the mitochondrial fusion protein Mfn2 causes mitochondrial dysfunction and cell death. Eur J Cell Biol. 2007;86:289–302.
doi: 10.1016/j.ejcb.2007.04.002

Auteurs

Diane Doummar (D)

APHP, Service de Neuropédiatrie, Hôpital Armand Trousseau, Sorbonne Université, 75012, Paris, France.
Centre de Référence Neurogénétique, Mouvement Anormaux de l'enfant, Hopital Armand Trousseau, 75012, Paris, France.

Christel Dentel (C)

Service de Neurologie, Centre Hospitalier Haguenau, Haguenau, France.

Romane Lyautey (R)

Department of Molecular and Cellular Genetics, CNRS, GMGM, UMR7156, Université de Strasbourg, Strasbourg, France.

Julia Metreau (J)

APHP, Service de neurologie pédiatrique, Hôpital Universitaire Bicetre, Le Kremlin-Bicetre, France.

Boris Keren (B)

APHP Département of Génétique, Hôpital Trousseau et Groupe Hospitalier Pitié-Salpêtrière, Sorbonne Université, Paris, France.

Nathalie Drouot (N)

Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS U7104, INSERM U1258, 67400, Illkirch, France.
Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.

Ludivine Malherbe (L)

Department of Molecular and Cellular Genetics, CNRS, GMGM, UMR7156, Université de Strasbourg, Strasbourg, France.

Viviane Bouilleret (V)

Service de neurophysiologie clinique et d'épileptologie, Hôpital Bicêtre, Assistance Publique des Hôpitaux de Paris, AP-HP, Le Kremlin-Bicêtre, France.

Jérémie Courraud (J)

Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS U7104, INSERM U1258, 67400, Illkirch, France.
Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.

Maria Paola Valenti-Hirsch (MP)

Service d'Epileptologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Lorella Minotti (L)

GIN, Inserm U1216, Neurology Department Grenoble-Alpes university and hospital, Grenoble, France.

Blandine Dozieres-Puyravel (B)

Service de Neurologie Pédiatrique, AP-HP, Hôpital Robert Debré, 75019, Paris, France.

Séverine Bär (S)

Department of Molecular and Cellular Genetics, CNRS, GMGM, UMR7156, Université de Strasbourg, Strasbourg, France.

Julia Scholly (J)

Service d'Epileptologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Elise Schaefer (E)

Laboratoire de Génétique médicale, UMR_S INSERM U1112, IGMA, Faculté de Médecine FMTS, Université de Strasbourg, Strasbourg, France.
Service de Génétique Médicale, IGMA, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Caroline Nava (C)

APHP Département of Génétique, Hôpital Trousseau et Groupe Hospitalier Pitié-Salpêtrière, Sorbonne Université, Paris, France.

Thomas Wirth (T)

Service des Pathologies du Mouvement, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Hala Nasser (H)

Service des Explorations Fonctionnelles, Hôpital Robert Debré, 75019, Paris, France.
Service de Génétique Clinique, Hôpital Robert Debré, 75019, Paris, France.

Marie de Salins (M)

APHP, Service de Neuropédiatrie, Hôpital Armand Trousseau, Sorbonne Université, 75012, Paris, France.

Anne de Saint Martin (A)

Service de Neurologie Pédiatrique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Marie Thérèse Abi Warde (MTA)

Service de Neurologie Pédiatrique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Philippe Kahane (P)

GIN, Inserm U1216, Neurology Department Grenoble-Alpes university and hospital, Grenoble, France.

Edouard Hirsch (E)

Service d'Epileptologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Mathieu Anheim (M)

Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS U7104, INSERM U1258, 67400, Illkirch, France.
Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.
Service de Neurologie, Centre de Références des Maladies Neurogénétique Rares, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Sylvie Friant (S)

Department of Molecular and Cellular Genetics, CNRS, GMGM, UMR7156, Université de Strasbourg, Strasbourg, France.

Jamel Chelly (J)

Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS U7104, INSERM U1258, 67400, Illkirch, France.
Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.
Service de Diagnostic Génétique, Hôpital Civil de Strasbourg, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Cyril Mignot (C)

APHP Département of Génétique, Hôpital Trousseau et Groupe Hospitalier Pitié-Salpêtrière, Sorbonne Université, Paris, France.
Centre de Référence Déficiences Intellectuelles de Causes Rares, Strasbourg, France.
INSERM, U 1127, CNRS UMR 7225, Sorbonne Université, UPMC Universié Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle Epinière, ICM, Paris, France.

Gabrielle Rudolf (G)

Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS U7104, INSERM U1258, 67400, Illkirch, France. Gabrielle.Rudolf@chru-strasbourg.fr.
Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France. Gabrielle.Rudolf@chru-strasbourg.fr.
Service d'Epileptologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. Gabrielle.Rudolf@chru-strasbourg.fr.
Service des Pathologies du Mouvement, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. Gabrielle.Rudolf@chru-strasbourg.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH